Codi QR

Phase II trial of neoadjuvant gemcitabine and cisplatin in patients with resectable bladder carcinoma

OBJECTIVES: Gemcitabine and cisplatin (GC) is an active combination in the treatment of metastatic bladder cancer. We have prospectively analyzed the efficacy and tolerability of GC as neoadjuvant treatment of invasive bladder cancer MATERIALS AND METHODS: In this single-institution phase II trial,...

Descripció completa

Guardat en:
Autors principals: Daniel Herchenhorn, Rodrigo Dienstmann, Fabio A. Peixoto, Franz S. de Campos, Valdelice O. Santos, Denise M. Moreira, Hedilene Cardoso, Isabele A. Small, Carlos G. Ferreira
Format: Artigo
Idioma:Inglês
Publicat: Sociedade Brasileira de Urologia 2007-10-01
Col·lecció:International Brazilian Journal of Urology
Matèries:
bladder neoplasms
neoadjuvant therapy
cisplatin
gemcitabine
Accés en línia:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382007000500004
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars